Dr. Goodenow is the Director of the Office of AIDS Research (OAR). She also holds the title of NIH Associate Director for AIDS Research. She received her Ph.D. in molecular genetics from the Albert Einstein College of Medicine in New York. Following a postdoctoral fellowship in molecular oncology at the Sloan Kettering Institute in New York, she was a visiting scientist at the Pasteur Institute in Paris, where she began her studies of HIV.
Read More

Statement on NIH Efforts to Focus Research to End the AIDS Pandemic

Released on August 12, 2015

Extraordinary progress has been made in HIV/AIDS research over the last 34 years, transforming what was once a terrifying and almost inevitably fatal disease into a treatable disorder. People with HIV/AIDS can now experience an almost normal life expectancy if antiretrovirals are started promptly and continued for life. Read More

NIH Overarching HIV/AIDS Research Priorities

NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding

The Office of AIDS Research (OAR), located within the National Institutes of Health (NIH), Office of the Director, Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), coordinates the scientific, budgetary, legislative, and policy elements of NIH HIV/AIDS research. The NIH represents the largest and most significant public investment in HIV/AIDS research in the world. Read More

• Drs. Goodenow and Fauci reflect on need for HIV vaccine
• Dr. Goodenow Addresses ATN
• OAR's blog post on HIV.gov: Benefits of HIV Research Go Beyond HIV
• Upcoming Office of AIDS Research Advisory Council (OARAC) Meetings
• Sponsored Events

• 2019 Congressional Justification Budget
• 2018 Professional Judgment Budget
• OARAC Roster
• NIH IC AIDS Coordinators (NIH Only)

• Funding Opportunities
• Submitting Grant Applications
• Research Training
• Scientific Resources
• Library and Literature Sources